a

Our People

Two decades of adipose tissue science in one place — spanning scientific, clinical, regulatory, and
commercial expertise. Collectively, the team has commercialized advanced cell therapies and medical
devices in Europe and authored more than 100 peer-reviewed publications, including publications in
NEJM and The Lancet.

People

Peter Selvig

Managing Director and Co-founder

M.Sc. in Innovation & Business Development (CBS / UW, Madison)

10 years international business development, marketing, trading and operations executive (Shell)

10 years in medical technology start-ups co-founding Stemform and StemMedical

Lea Munthe-Fog, PhD

Chief Science Officer

PhD in Molecular Biology

Former Head of Production and Cellular Research, StemMedical. Former Head of GMP Production, Copenhagen University Hospital

60+ publications in peer-reviewed journals incl.New England Journal of Medicine

Anne Fischer-Nielsen, MD, PhD

Head of Quality & Regulatory

Board certified clinical immunologist

Former co-founder and Head of Quality & Regulatory at StemMedical. Former Associate Professor in Immunology, Head of Cell
Therapy and GMP Responsible, Copenhagen University Hospital

60+ publications in peer-reviewed journals including The Lancet

Jesper Svalgaard, PhD

Senior Scientist & Head of Lab

PhD in Molecular Biology

Former senior scientist at StemMedical and Copenhagen University Hospital

20+ publications in peer-reviewed journals

Strategic Advisors

Marko Rackovic

CEO and Board member at Vivostat A/S

Co-founder of Danske Privathospitaler (Danish Private

20+ years in the MedTech industry

Clinical Advisors

Tina Holten

Owner Director, Bloom Copenhagen

15+ years of expertise in aesthetic treatments and patient care

Leading aesthetic practice entrepreneur

Bo Jønsson, MD

Plastic Surgeon, Aleris

Co-founder of Danske Privathospitaler

25 years of plastic surgery experience with extensive involvement in clinical development programs and new treatment introductions